ArticleThe Pan African medical journal2016
Feasibility and acceptability of oral cholera vaccine mass vaccination campaign in response to an outbreak and floods in Malawi.
Article in The Pan African medical journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.
- The practice of evaluating epidemic response in humanitarian and low-income settings: a systematic review.BMC medicine · 2020Pooled it
- Relative contributions of public and domestic transmission domains in cholera outbreaks in displacement camps: an exploratory agent-based modeling study.Epidemiology and infection · 2026Article
- Effects of tropical cyclone Freddy on the social determinants of health: the narrative review of the experience in Malawi.BMJ public health · 2024Review
- The reactive cholera vaccination campaign in urban Dhaka in 2022: experience, lessons learned and future directions.Public health in practice (Oxford, England) · 2024Review
- Rapid cholera outbreak control following catastrophic landslides and floods: A case study of Bududa district, Uganda.African health sciences · 2023Article
- A scoping review of facilitators and barriers influencing the implementation of surveillance and oral cholera vaccine interventions for cholera control in lower- and middle-income countries.BMC public health · 2023Article
- Controlled Human Infection Models To Accelerate Vaccine Development.Clinical microbiology reviews · 2022Review
- Economic impact of cholera in households in rural southern Malawi: a prospective study.BMJ open · 2022Article
- An innovative approach in monitoring oral cholera vaccination campaign: integration of a between-round survey.BMC public health · 2022Article
- Costing oral cholera vaccine delivery using a generic oral cholera vaccine delivery planning and costing tool (CholTool).Human vaccines & immunotherapeutics · 2020Article
- The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey.BMJ global health · 2020Article
- Global oral cholera vaccine use, 2013-2018.Vaccine · 2020Review
- The multi-sectorial emergency response to a cholera outbreak in Internally Displaced Persons camps in Borno State, Nigeria, 2017.BMJ global health · 2020Article
- Comparing alternative cholera vaccination strategies in Maela refugee camp: using a transmission model in public health practice.BMC infectious diseases · 2019Article
- Review
- Review
- Article
- Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique.PloS one · 2018Article
- Identifying cholera "hotspots" in Uganda: An analysis of cholera surveillance data from 2011 to 2016.PLoS neglected tropical diseases · 2017Article
- Oral cholera vaccine coverage in hard-to-reach fishermen communities after two mass Campaigns, Malawi, 2016.Vaccine · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 4 institutions in 3 countries.
Funding
Abstract
introductionDespite some improvement in provision of safe drinking water, proper sanitation and hygiene promotion, cholera still remains a major public health problem in Malawi with outbreaks occurring almost every year since 1998. In response to 2014/2015 cholera outbreak, ministry of health and partners made a decision to assess the feasibility and acceptability of conducting a mass oral cholera vaccine (OCV) as an additional public health measure. This paper highlights the burden of the 2014/15 cholera outbreak, successes and challenges of OCV campaign conducted in March and April 2015.
methodsThis was a documentation of the first OCV campaign conducted in Malawi. The campaign targeted over 160,000 people aged one year or more living in 19 camps of people internally displaced by floods and their surrounding communities in Nsanje district. It was a reactive campaign as additional measure to improved water, sanitation and hygiene in response to the laboratory confirmed cholera outbreak.
resultsDuring the first round of the OCV campaign conducted from 30 March to 4 April 2015, a total of 156,592 (97.6%) people out of 160,482 target population received OCV. During the second round (20 to 25 April 2015), a total of 137,629 (85.8%) people received OCV. Of these, 108,247 (67.6%) people received their second dose while 29,382 (18.3%) were their first dose. Of the 134,836 people with known gender and sex who received 1 or 2 doses, 54.4% were females and over half (55.4%) were children under the age of 15 years. Among 108,237 people who received 2 doses (fully immunized), 54.4% were females and 51.9% were children under 15 years of age. No severe adverse event following immunization was reported. The main reason for non-vaccination or failure to take the 2 doses was absence during the period of the campaign.
conclusionThis documentation has demonstrated that it was feasible, acceptable by the community to conduct a large-scale mass OCV campaign in Malawi within five weeks. Of 320,000 OCV doses received, Malawi managed to administer at least 294,221 (91.9%) of the doses. OCV could therefore be considered to be introduced as additional measure in cholera hot spot areas in Malawi.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.